- Home
- MGRM vs TLSA Comparison
MGRM vs TLSA Comparison
Compare MGRM & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRM
- TLSA
- Stock Information
- Founded
- MGRM 2016
- TLSA 2013
- Country
- MGRM United States
- TLSA United Kingdom
- Employees
- MGRM N/A
- TLSA N/A
- Industry
- MGRM Medical/Dental Instruments
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- MGRM Health Care
- TLSA Health Care
- Exchange
- MGRM Nasdaq
- TLSA Nasdaq
- Market Cap
- MGRM 198.9M
- TLSA 187.0M
- IPO Year
- MGRM N/A
- TLSA 2000
- Fundamental
- Price
- MGRM $5.94
- TLSA $1.58
- Analyst Decision
- MGRM Strong Buy
- TLSA
- Analyst Count
- MGRM 1
- TLSA 0
- Target Price
- MGRM $5.40
- TLSA N/A
- AVG Volume (30 Days)
- MGRM 127.1K
- TLSA 364.9K
- Earning Date
- MGRM 08-15-2025
- TLSA 05-06-2025
- Dividend Yield
- MGRM N/A
- TLSA N/A
- EPS Growth
- MGRM N/A
- TLSA N/A
- EPS
- MGRM N/A
- TLSA N/A
- Revenue
- MGRM N/A
- TLSA N/A
- Revenue This Year
- MGRM N/A
- TLSA N/A
- Revenue Next Year
- MGRM N/A
- TLSA N/A
- P/E Ratio
- MGRM N/A
- TLSA N/A
- Revenue Growth
- MGRM N/A
- TLSA N/A
- 52 Week Low
- MGRM $1.92
- TLSA $0.63
- 52 Week High
- MGRM $6.02
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- MGRM 73.81
- TLSA 36.70
- Support Level
- MGRM $5.34
- TLSA $1.73
- Resistance Level
- MGRM $6.02
- TLSA $1.90
- Average True Range (ATR)
- MGRM 0.14
- TLSA 0.15
- MACD
- MGRM 0.02
- TLSA -0.05
- Stochastic Oscillator
- MGRM 89.33
- TLSA 5.17
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.